These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12929451)

  • 1. Synthesis, biological evaluation and DNA binding properties of novel mono and bisnaphthalimides.
    Braña MF; Cacho M; Ramos A; Domínguez MT; Pozuelo JM; Abradelo C; Rey-Stolle MF; Yuste M; Carrasco C; Bailly C
    Org Biomol Chem; 2003 Feb; 1(4):648-54. PubMed ID: 12929451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antitumor activity, molecular modeling, and DNA binding properties of a new series of imidazonaphthalimides.
    Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle MF; Yuste M
    J Med Chem; 2002 Dec; 45(26):5813-6. PubMed ID: 12477366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-naphthalimides: a new class of antitumor agents.
    Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
    Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis-naphthylureas and related compounds: synthesis, chemical properties, DNA affinity and antineoplastic activity.
    Bruno AM; Asis SE; Gaozza CH
    Pharmazie; 2001 May; 56(5):361-5. PubMed ID: 11400549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antitumor evaluation and DNA photocleaving activity of novel methylthiazonaphthalimides with aminoalkyl side chains.
    Li Z; Yang Q; Qian X
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3143-6. PubMed ID: 15876532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
    Li Z; Yang Q; Qian X
    Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
    J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives.
    Siwy M; Sek D; Kaczmarczyk B; Jaroszewicz I; Nasulewicz A; Pelczyñska M; Nevozhay D; Opolski A
    J Med Chem; 2006 Jan; 49(2):806-10. PubMed ID: 16420065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.
    Quintana-Espinoza P; García-Luis J; Amesty A; Martín-Rodríguez P; Lorenzo-Castrillejo I; Ravelo AG; Fernández-Pérez L; Machín F; Estévez-Braun A
    Bioorg Med Chem; 2013 Nov; 21(21):6484-95. PubMed ID: 24054489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II Inhibitors.
    Eissa IH; El-Naggar AM; El-Sattar NEAA; Youssef ASA
    Anticancer Agents Med Chem; 2018; 18(2):195-209. PubMed ID: 28699490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, DNA-binding and cytotoxicity evaluation of new potential combilexines.
    Hotzel C; Marotto A; Pindur U
    Eur J Med Chem; 2002 May; 37(5):367-78. PubMed ID: 12008051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.
    Jiang H; Zhang WJ; Li PH; Wang J; Dong CZ; Zhang K; Chen HX; Du ZY
    Bioorg Med Chem Lett; 2018 May; 28(8):1320-1323. PubMed ID: 29545100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
    Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
    J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.
    Blanchard S; Rodriguez I; Tardy C; Baldeyrou B; Bailly C; Colson P; Houssier C; Léonce S; Kraus-Berthier L; Pfeiffer B; Renard P; Pierré A; Caubère P; Guillaumet G
    J Med Chem; 2004 Feb; 47(4):978-87. PubMed ID: 14761199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of "minimal" DNA-intercalating agents which may not act via topoisomerase II.
    Denny WA; Rewcastle GW; Baguley BC
    J Med Chem; 1990 Feb; 33(2):814-9. PubMed ID: 2153829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono- and bisfuronaphthalimides.
    Bailly C; Carrasco C; Joubert A; Bal C; Wattez N; Hildebrand MP; Lansiaux A; Colson P; Houssier C; Cacho M; Ramos A; Braña MF
    Biochemistry; 2003 Apr; 42(14):4136-50. PubMed ID: 12680768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-member thio-heterocyclic fused naphthalimides with aminoalkyl side chains: intercalation and photocleavage to DNA.
    Xu Y; Qu B; Qian X; Li Y
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1139-42. PubMed ID: 15686929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
    Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.
    Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Domínguez MT; Pozuelo JM; Abradelo C; Rey-Stolle MF; Yuste M; Báñez-Coronel M; Lacal JC
    J Med Chem; 2004 Mar; 47(6):1391-9. PubMed ID: 14998328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; Barone V; Pani A; Tramontano E; La Colla P; Murgioni C; Serra I; Setzu G; Loddo R
    J Med Chem; 2002 Nov; 45(24):5205-16. PubMed ID: 12431048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.